Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

TBIO

Telesis Bio (TBIO)

Telesis Bio Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:TBIO
DateTimeSourceHeadlineSymbolCompany
06/12/20244:00PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TBIOTelesis Bio Inc
06/10/20247:40PMEdgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:TBIOTelesis Bio Inc
06/10/20247:30PMEdgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:TBIOTelesis Bio Inc
05/10/20245:04AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TBIOTelesis Bio Inc
05/09/20243:15PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TBIOTelesis Bio Inc
05/09/20243:05PMGlobeNewswire Inc.Telesis Bio Reports First Quarter 2024 Financial ResultsNASDAQ:TBIOTelesis Bio Inc
05/06/20243:30PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TBIOTelesis Bio Inc
05/06/20243:05PMGlobeNewswire Inc.Telesis Bio Announces Reverse Stock SplitNASDAQ:TBIOTelesis Bio Inc
04/18/20248:00AMGlobeNewswire Inc.Telesis Bio Inc. announces strategic focus on game-changing Gibson SOLA enzymatic DNA synthesis (EDS) platform and BioXp mRNA solutions and announces new leadershipNASDAQ:TBIOTelesis Bio Inc
03/28/20243:05PMGlobeNewswire Inc.Telesis Bio Reports Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:TBIOTelesis Bio Inc
03/05/20245:55PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TBIOTelesis Bio Inc
03/05/20245:40PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TBIOTelesis Bio Inc
03/05/20245:07PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TBIOTelesis Bio Inc
02/29/20247:15PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TBIOTelesis Bio Inc
02/29/20247:10PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TBIOTelesis Bio Inc
02/26/20244:00PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TBIOTelesis Bio Inc
02/26/20248:15AMGlobeNewswire Inc.Telesis Bio Announces Select Preliminary Fourth Quarter 2023 Financial ResultsNASDAQ:TBIOTelesis Bio Inc
11/30/20234:00PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TBIOTelesis Bio Inc
11/13/20233:32PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TBIOTelesis Bio Inc
11/13/20233:32PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TBIOTelesis Bio Inc
11/13/20233:22PMGlobeNewswire Inc.Telesis Bio Reports Third Quarter 2023 Financial ResultsNASDAQ:TBIOTelesis Bio Inc
11/09/20234:00PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TBIOTelesis Bio Inc
11/07/20238:00AMGlobeNewswire Inc.Telesis Bio to Report Third Quarter Financial Results on Monday, November 13, 2023NASDAQ:TBIOTelesis Bio Inc
11/03/202311:00AMGlobeNewswire Inc.Telesis Bio Announces Commercial Release of Cell-free Amplification Kit for Generation of Transfection-scale DNANASDAQ:TBIOTelesis Bio Inc
10/24/20233:30PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TBIOTelesis Bio Inc
09/28/20232:48PMGlobeNewswire Inc.Telesis Bio Announces Commercial Release of BioXp® NGS Library Prep Kit for WGSNASDAQ:TBIOTelesis Bio Inc
09/22/20234:00PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TBIOTelesis Bio Inc
08/29/20233:05PMGlobeNewswire Inc.Telesis Bio Appoints William J. Kullback Chief Financial OfficerNASDAQ:TBIOTelesis Bio Inc
08/29/20233:02PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TBIOTelesis Bio Inc
08/11/20235:01AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TBIOTelesis Bio Inc
 Showing the most relevant articles for your search:NASDAQ:TBIO